The novel therapy of tirzepatide peptide represents a significant advance in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide919316.dbblog.net/15424661/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment